Both in Pharmaceuticals
Syndax Pharmaceuticals vs Alto Neuroscience
Over the past year SNDX returned −31.9% and ANRO returned +107.5%; their daily moves had a correlation of 0.27.
SNDX −31.9% ANRO +107.5%Growth of $1, one year, split-adjusted
| Metric | SNDX | ANRO |
|---|---|---|
| Price | $10.45 | $23.30 |
| Market cap | $933.2M | $914.3M |
| Today | −26.87% | +2.64% |
| 1 month | −39.8% | −1.6% |
| 6 months | −49.4% | −4.9% |
| Year to date | −50.3% | +30.9% |
| 1 year | −24.1% | +91.5% |
| Revenue growth (YoY) | +81.6% | — |
| Gross margin | 83.2% | — |
| Net margin | −59.3% | — |
| P/E (TTM) | — | — |
| Price / sales | 3.2× | — |
| Net cash | $182.3M | $225.1M |
| Dividend yield | — | — |
| Volatility (60d) | 84.0% | 56.5% |
| Short % of float | 21.4% | 20.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).